The
global cell separation market is poised
to grow by USD 7.12 billion during 2020-2024, progressing at a CAGR of over 17%
during the forecast period.
The market is driven by the increasing use of cell separation in cancer
research. In addition, the rising focus on personalized medicine is anticipated
to further boost the growth of the cell separation market.
The increasing use of cell separation in cancer research will be one of
the major drivers in the global market. Over the last few years, cell
separation has been used along with imaging, proteomics, and molecular
biological methods to identify and characterize cancer stem cells. This helps
in the early diagnosis of tumors, monitoring of circulating tumor cells, and
evaluation of intratumor heterogeneity. Also, the incidence of cancer is
increasing rapidly, especially amongst women. Cervical and breast cancers are
the most common types in the world. The rising incidence of cancer is
encouraging further research in the field. Moreover, advances in computer
techniques, optics, and lasers introduced a new generation of cell separation
techniques which are capable of high speed processing of single cell
suspensions. These factors will boost the global cell separation market growth
during the forecast period of 2020-2024.
Buy 1 Technavio report and get the
second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before
purchasing
Major Five Cell Separation Market Companies:
Akadeum Life Sciences
Akadeum Life Sciences owns and operates the businesses under various
segments such as T cell isolation kits, B cell isolation kits, red blood cell
products, Streptavidin products, and CD45 products. The product offered by the
company is human T Cell isolation kit. This product uses
streptavidin-conjugated BACS microbubbles and biotinylated antibodies for cell
separation.
Becton, Dickinson and Co.
Becton operates the business under three segments, which include BD
medical, BD life sciences, and BD interventional. The company’s key offering
include the BD IMag cell separation magnet. This product is used to attract
labeled cells to the adjacent walls of tubes, allowing the removal of the
supernatant, which contains unlabeled cells.
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. has business operations under various
segments, namely life science and clinical diagnostics. The product offered by
the company is the ddSEQ single-cell isolator. This product is offered as an
automated device to process hundreds to tens of thousands of cells per day.
Cell Microsystems, Inc.
Cell Microsystems, Inc. operates the business under three segments,
which include CellRaft AIR System, CytoSort Array, and CellRaft System for
inverted microscopes. The company’s key offerings include the CellRaft AIR
System. This product is available with an automated precision X-Y stage and a
microscope with three-channel fluorescence imaging capabilities. It is designed
to reduce the time taken for cell separation.
Danaher Corp.
Danaher Corp. operates the business through the following segments: Life
Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The
company’s key offering in the cell separation market include Avanti J-26S XP.
This product is offered as a centrifuge, which includes the elutriation
particle separation functionality.
No comments:
Post a Comment